The Lancet

Who to test and reflex testing for hepatitis D virus infection: evidence and rationale to inform policy recommendations and future directions

Chronic hepatitis D coinfection affects an estimated 12 million people globally, with higher prevalence in low-income and middle-income countries, especially the African and Western Pacific regions.
Nasdaq

Amedisys Offers Molecular Testing for Rapid and Accurate Infection Diagnosis

BATON ROUGE, La., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, is now offering advanced molecular ...
EurekAlert!

Study shows hospital policy allowing nurses to initiate C. difficile testing could reduce infection spread and associated morbidity

Arlington, Va., May 11, 2023 – A new study published today in the American Journal of Infection Control (AJIC) suggests that allowing bedside nurses to independently order testing for C. difficile ...
UC San Francisco

1 Genomic Test Can Diagnose Nearly Any Infection

A genomic test developed at UC San Francisco to rapidly detect almost any kind of pathogen – virus, bacteria, fungus or parasite – has proved successful after a decade of use. The test has the ...
The Lancet

How to test for hepatitis D virus infection: evidence and rationale to inform policy recommendations and future directions

Chronic hepatitis D virus (HDV) coinfection in people with chronic hepatitis B is associated with rapid progression to liver cirrhosis and high mortality. In 2020, the estimated global HDV burden ...